PE/VC  Abingworth

https://www.abingworth.com/





     Office Locations:

3000 Sand Hill Road
Bldg. 4, Suite 135
Menlo Park, CA 94025
Phone: 650-926-0600
Fax: 650-926-9782

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth
  • Late
  • Middle Market


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 1973, Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. The company invests across all stages of company development including early and late-stage venture financing, growth equity, and public companies. With offices in London, Boston and Menlo Park, Abingworth has backed more than 100 developing life science/medical businesses, over two-thirds of which have gone public, merged, or been acquired. Abingworth has funds under management of more than $1.25 billion. The firm has raised eleven funds since it was founded in 1973, the last nine of which have been entirely dedicated to life sciences and healthcare. Abingworth's investments are based in the U.S. and Europe including the U.K., Belgium, Denmark, France, Germany, Holland and Sweden. The firm's investments range from $15-30 million over more than one round of financing. In February 2014, the firm announced the final closing of its POUND 225M ($375M) fund, Abingworth Bioventures VI (ABV VI). ABV VI is Abingworth's 10th life sciences fund.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Andrew Sinclair Partner
    Genghis Lloyd-Harris Managing Partner
    James Abell Senior Advisor
    John Heard Partner and General Counsel
    Kurt Von Emster Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/08/2021


      HilleVax


      MA


      $135,000,000


      Crossover Financing


      06/23/2021


      Glycomine


      CA


      $68,000,000


      Series B


      01/22/2021


      Vera Therapeutics


      CA


      $80,000,000


      Series C


      12/16/2020


      Atsena Therapeutics


      NC


      $55,000,000


      Series A


     

    Portfolio companies include:


      Atsena Therapeutics
        web link


      Attenua
        web link


      Chiasma
        web link


      Dicerna Pharmaceuticals
        web link


      Effector Therapeutics
        web link


      Glycomine
        web link


      Gynesonics
        web link


      HilleVax
        web link


      IFM Therapeutics
        web link


      ï¿½Reneo Pharmaceuticals


      Jasper Therapeutics
        web link


      Labcyte
        web link


      Personalis
        web link


      Proteon Therapeutics
        web link


      Scorpion Therapeutics
        web link


      SutroVax
        web link


      Tizona Therapeutics
        web link


      VenatoRx Pharmaceuticals
        web link


      Vera Therapeutics
        web link


      Wilson Therapeutics
        web link


     

    Recent News: